Rene Goehrum - Net Worth and Insider Trading
Rene Goehrum Net Worth
The estimated net worth of Rene Goehrum is at least $11 Million dollars as of 2024-11-09. Rene Goehrum is the 10% Security Holder, Director, Senior Officer of Biosyent Inc and owns about 997,970 shares of Biosyent Inc (TSXV:RX) stock worth over $11 Million. Details can be seen in Rene Goehrum's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Rene Goehrum has not made any transactions after 2024-06-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Rene Goehrum
Rene Goehrum Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Rene Goehrum owns 1 companies in total, including Biosyent Inc (TSXV:RX) .
Click here to see the complete history of Rene Goehrum’s form 4 insider trades.
Insider Ownership Summary of Rene Goehrum
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSXV:RX | Biosyent Inc | 2024-06-12 | 10% Security Holder & Director & Senior Officer |
Rene Goehrum Latest Holdings Summary
Rene Goehrum currently owns a total of 1 stock. Rene Goehrum owns 997,970 shares of Biosyent Inc (TSXV:RX) as of June 12, 2024, with a value of $11 Million.
Latest Holdings of Rene Goehrum
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSXV:RX | Biosyent Inc | 2024-06-12 | 997,970 | 11.15 | 11,127,366 |
Holding Weightings of Rene Goehrum
Rene Goehrum Form 4 Trading Tracker
According to the SEC Form 4 filings, Rene Goehrum has made a total of 2 transactions in Biosyent Inc (TSXV:RX) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Biosyent Inc is the sale of 1,522 shares on June 12, 2024, which brought Rene Goehrum around $14,276.
Insider Trading History of Rene Goehrum
- 1
Rene Goehrum Trading Performance
GuruFocus tracks the stock performance after each of Rene Goehrum's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Rene Goehrum is 38.5%. GuruFocus also compares Rene Goehrum's trading performance to market benchmark return within the same time period. The performance of stocks bought by Rene Goehrum within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Rene Goehrum's insider trading performs compared to the benchmark.
Performance of Rene Goehrum
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 20.22 | | | | | |
| Relative Return to S&P 500(%) | 10.7 | | | | | |
Rene Goehrum Ownership Network
Ownership Network List of Rene Goehrum
Ownership Network Relation of Rene Goehrum
Rene Goehrum Owned Company Details
What does Biosyent Inc do?
Who are the key executives at Biosyent Inc?
Rene Goehrum is the 10% Security Holder & Director & Senior Officer of Biosyent Inc. Other key executives at Biosyent Inc include Senior Officer Sharan Raghubir , Issuer BioSyent Inc. , and Senior Officer Joost van der Mark .
Biosyent Inc (TSXV:RX) Insider Trades Summary
Over the past 18 months, Rene Goehrum made 1 insider transaction in Biosyent Inc (TSXV:RX) with a net sale of 1,522. Other recent insider transactions involving Biosyent Inc (TSXV:RX) include a net sale of 6,304 shares made by Seyed Ahmad Ashrafi , a net sale of 5,505 shares made by Sharan Raghubir , and a net sale of 1,235 shares made by Peter Douglas Lockhard .
In summary, during the past 3 months, insiders sold 5,939 shares of Biosyent Inc (TSXV:RX) in total and bought 0 shares, with a net sale of 5,939 shares. During the past 18 months, 14,566 shares of Biosyent Inc (TSXV:RX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 14,566 shares.
Biosyent Inc (TSXV:RX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Biosyent Inc Insider Transactions
Rene Goehrum Mailing Address
Above is the net worth, insider trading, and ownership report for Rene Goehrum. Currently GuruFocus does not have mailing address information for Rene Goehrum.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
